Source:http://linkedlifedata.com/resource/pubmed/id/20030931
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-12-24
|
pubmed:abstractText |
This study was purposed to investigate the effect of AML1-ETO fusion protein resulted from hematopoietic transcription factor (AML1) and acute myeloid leukemia M(2b)(AML-M(2b)) on transcription activity of nucleobindin 2 (nucb2) promoter, and to explore the role of AML1-ETO in molecular pathogenesis of AML-M(2b). The real-time RT-PCR was used to study the regulation of AML1-ETO on nucb2 at transcription level in AML1-ETO inducible leukemia cell line, the chromatin immunoprecipitation (ChIP)-based qPCR was used to investigate the direct in vivo interaction between the AML1, AML1-ETO and nucb2 promoter in AML1-ETO positive leukemia cell line, the luciferase report gene assay was used to detect the regulation of AML1, AML1-ETO on the transcription activity of nucb2 promoter. The results showed that the expression level of nucb2 was reduced with the increase of AML1-ETO. The promoter of nucb2 could be bound by both AML1 and AML1-ETO. The promoter of nucb2 was trans-repressed by AML1 and AML1-ETO respectively. It is concluded that the nucb2 is the direct target gene of AML1 and AML1-ETO, the transcription regulation of AML1, AML1-ETO on nucb2 is carried out via repressing its promoter activity.
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AML1-ETO fusion protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Core Binding Factor Alpha 2 Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/nucleobindin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1009-2137
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1482-6
|
pubmed:meshHeading |
pubmed-meshheading:20030931-Calcium-Binding Proteins,
pubmed-meshheading:20030931-Cell Line, Tumor,
pubmed-meshheading:20030931-Core Binding Factor Alpha 2 Subunit,
pubmed-meshheading:20030931-DNA-Binding Proteins,
pubmed-meshheading:20030931-Gene Expression Regulation, Leukemic,
pubmed-meshheading:20030931-Humans,
pubmed-meshheading:20030931-Oncogene Proteins, Fusion,
pubmed-meshheading:20030931-Promoter Regions, Genetic,
pubmed-meshheading:20030931-Transcription Factors,
pubmed-meshheading:20030931-Transcriptional Activation
|
pubmed:year |
2009
|
pubmed:articleTitle |
[Influence of AML1 and AML1-ETO on transcriptional regulation of nucb2 gene].
|
pubmed:affiliation |
National Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University Medical College, Shanghai 200025, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|